Beata Korytowsky

Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Mark R. Olsen et al. · Journal of Clinical Oncology · 2012 · 275 citations · Full text

Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)

David R. Spigel, Michael McCleod, Robert M. Jotte et al. · Journal of Thoracic Oncology · 2019 · 184 citations

Checkmate 153, Oncology, Cancer Management +8

Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials

Ana M. Molina, Xun Lin, Beata Korytowsky et al. · European Journal of Cancer · 2013 · 157 citations

Urology, Genitourinary Cancer, Medicine +9

Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial

Alfredo Carrato, Anna Świeboda-Sadlej, Marzanna Staszewska-Skurczyńska et al. · Journal of Clinical Oncology · 2013 · 132 citations · Full text

Estimating 1- and 5-year relative survival trends in colorectal cancer (CRC) in the United States: 2004 to 2014.

Hannah Crooke, Monica Kobayashi, Brian Mitchell et al. · Journal of Clinical Oncology · 2018 · 56 citations

Surgical Oncology, Elderly Patients, Cancer Management +18